1. Home
  2. SANA

SANA

Sana Biotechnology Inc.

Logo Sana Biotechnology Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others.

Founded: 2018 Country:
United States
United States
Employees: 328 City: SEATTLE
Market Cap: 2.0B IPO Year: 2021
Target Price: $11.67 AVG Volume (30 days): 2.1M
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.46 EPS Growth: N/A
52 Week Low/High: $2.75 - $12.00 Next Earning Date: 05-06-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: